RPA2 · Western blot design guide

RPA2 Western Blot Planning Guide

Plan a RPA2 Western blot around the catalog-observed 29.2 kDa band, image-backed A02067-1 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for RPA2 (RPA2): expected band 29.2 kDa, antibody A02067-1, and guide-derived SDS-PAGE protocol steps
RPA2 Western blot protocol sheet — expected band 29.2 kDa, antibody A02067-1, controls and PMC citations. Open the full RPA2 WB guide →

RPA2 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 29.2 kDa
Observed band Not reported — verify product WB image
Gel 12-15%
Positive control ⓘ Breast
Negative control ⓘ Target knockdown/knockout
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 29.2 kDa
ⓘ Localization Nucleus / Nucleus, PML body
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human
Section 1

Real Curated RPA2 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdrenal gland
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, short transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA02067-1 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected RPA2 Western Blot Band Size?

Use the product-observed 29.2 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
29.2 kDaMatches the authoritative product WB observation.
29.2 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected RPA2 appearancePlan around 29.2 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band29.2 kDa; use this as the primary experimental expectation.
Calculated mass29.2 kDa from UniProt P15927; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A02067-1.
Why is my band missing or off?
SituationLikely causeNext action
29.2 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for RPA2 Western blot

🧪Use Breast as the first positive-control candidate; no defensible HPA Not detected tissue was available, so use a target knockdown/knockout negative control.
Positive control: Breast (High)
Negative control: Target knockdown/knockout
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for RPA2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Breast Reported tissue cells High Protein (HPA) HPA →
Adrenal gland Reported tissue cells High Protein (HPA) HPA →
Appendix Reported tissue cells High Protein (HPA) HPA →
Bone marrow Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Section 3

Advanced RPA2 Western Blot Tips

Deeper troubleshooting and optimisation questions for RPA2, answered from its protein features.

Which band should guide the blot?
Use 29.2 kDa, the observation attached to the authoritative A02067-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 29.2 kDa expectation.
Which positive control should I start with?
Start with Breast, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use a target knockdown/knockout control when no HPA Not detected tissue is available.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for RPA2 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A02067-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

RPA2 Western Blot Reagents

Human-reactive RPA2 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for RPA2 using A02067-1; observed band 29.2 kDa
Anti-RPA32/RPA2 Antibody Picoband®
Cat # A02067-1
Real WB data Western blot validation image for RPA2 using M02067-2; observed band 29.2 kDa
Anti-RPA32/RPA2 Antibody Picoband® (monoclonal, 3B2E9)
Cat # M02067-2

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt P15927
  2. Human Protein Atlas — RPA2
  3. A02067-1 product record
  4. PMC2764457 — Ionizing radiation-dependent and independent phosphorylation of the 32-kDa subunit of replication protein A during mitosis (Nucleic acids research, 2009)